Montes, Lim N.

HRN: 06-25-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/08/2025
08/15/2025
IVTT
500MG
Q8
T/C IIH
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: